Weiwei Li

Dr. Weiwei Li


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2016 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
JLJing-Kun Li
Jing-Kun Li
LNLin Nie
Lin Nie
WLWeiwei Li
Weiwei Li
YZYuanqiang Zhang
Yuanqiang Zhang
XWXiaoqing Wang
Xiaoqing Wang
LCLei Cheng
Lei Cheng
Low back pain and sciatica caused by intervertebral disc (IVD) disease are associated with inflammatory responses. The cytokine interleukin 17 (IL-17) is elevated in herniated and degenerated IVD tissues and acts as a regulator of disc inflammation. The objective of this study was to investigate the involvement of IL-17A in IVD inflammatory response and to explore the mechanisms underlying this response. Cells were isolated from nucleus pulposus (NP) tissues collected from patients undergoing surgeries for IVD degeneration. The concentrations of COX2 and PGE2, as well as of select proteins involved in the mitogen-activated protein kinase (MAPK)/activating protein-1 (AP-1) pathway, were quantified in NP cells after exposure to IL-17 with or without pretreatment with MAPK or AP-1 inhibitors. Our results showed that IL-17A increased COX2 expression and PGE2 production via the activation of MAPKs, including p38 kinase and Jun N-terminal kinase (JNK). Moreover, IL-17A-induced COX2 and PGE2 production was shown to rely on p38/c-Fos and JNK/c-Jun activation in an AP-1-dependent manner. In summary, our results indicate that IL-17A enhances COX2 expression and PGE2 production via the p38/c-Fos and JNK/c-Jun signalling pathways in NP cells to mediate IVD inflammation.

3 January 2018 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
RQRuize Qu
Ruize Qu
XCXiaomin Chen
Xiaomin Chen
WWWenhan Wang
Wenhan Wang
CQCheng Qiu
Cheng Qiu
MBMiaomiao Ban
Miaomiao Ban
WLWeiwei Li
Weiwei Li
Osteoarthritis (OA) is a common chronic degenerative disease characterized by degeneration in the joints and subsequent destruction of cartilage and bone, yet much remains to be elucidated regarding its molecular mechanism. Ghrelin is a recently discovered neuropeptide with anti‐inflammatory actions, but it is unknown whether ghrelin is involved in OA. Human primary chondrocyte and cartilage samples were collected from patients with OA, and the expression pattern of ghrelin was assessed. Human chondrocyte and cartilage samples were stimulated with IL‐1β and TNF‐α, and exogenous ghrelin‐alleviated disorganization of catabolism and anabolism were mediated by IL‐1β and TNF‐α. Destabilization of the medial meniscus and anterior cruciate ligament transection models were established in wild‐type mice that were administered ghrelin or PBS. Severity of inflammation and degeneration in the joints were determined by measuring the levels of various inflammatory cytokines and degeneration‐associated molecules. Ghrelin down‐regulated the production of various inflammatory cytokines, inhibited apoptosis of chondrocytes, decreased the levels of metalloproteinases (including matrix metalloproteinase‐13 and a disintegrin and metalloproteinase with thrombospondin motif‐5), and maintained the expression of critical matrix components, such as aggrecan and collagen 2. Moreover, suppression of the Akt signaling pathway and activation of NF‐κB signaling in chondrocytes during OA development was antagonized by ghrelin administration. This supports the assessment of ghrelin as a potential therapeutic approach to treat degenerative cartilage diseases, including OA.—Qu, R., Chen, X., Wang, W., Qiu, C., Ban, M., Guo, L., Vasilev, K., Chen, J., Li, W., Zhao, Y. Ghrelin protects against osteoarthritis through interplay with Akt and NF‐κB signaling pathways. FASEB J. 32, 1044–1058 (2018). www.fasebj.org

5 October 2015 in Inflammation
Verified
Journal Article
Closed access
PDF file
WLWeiwei Li
Weiwei Li
ZLZhong Li
Zhong Li
WWWenhan Wang
Wenhan Wang
HZHui Zhang
Hui Zhang
JCJianying Chen
Jianying Chen
WLWeiwei Li
Weiwei Li

4 February 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RQRuize Qu
Ruize Qu
XCXiaomin Chen
Xiaomin Chen
JHJing Hu
Jing Hu
YFYufeng Fu
Yufeng Fu
JPJiangfan Peng
Jiangfan Peng
WLWeiwei Li
Weiwei Li
Contact dermatitis and psoriasis are skin disorders caused by immune dysregulation, yet much remains unknown about their underlying mechanisms. Ghrelin, a recently discovered novel peptide and potential endogenous anti-inflammatory factor expressed in the epidermis, is involved in skin repair and disease. In this study, we investigated the expression pattern and therapeutic effect of ghrelin in both contact dermatitis and psoriasis mouse models induced by oxazolone (OXA) and imiquimod (IMQ), respectively, and in TNF-α-stimulated RAW264.7 macrophages, NHEKs and skin fibroblasts. Ghrelin expression was reduced in both the OXA-induced contact dermatitis and IMQ-induced psoriasis mouse models. Furthermore, treatment with ghrelin attenuated skin inflammation in both the contact dermatitis and psoriasis mouse models. Mice administered PBS after OXA- or IMQ-induced model generation exhibited typical skin inflammation, whereas ghrelin treatment in these mouse models substantially decreased the dermatitis phenotype. In addition, exogenous ghrelin attenuated the inflammatory reaction induced by TNF-α in RAW264.7 cells. Moreover, ghrelin administration limited activation of NF-κB signaling. In summary, ghrelin may represent a potential molecular target for the prevention and treatment of inflammatory skin diseases, including contact dermatitis and psoriasis.

16 March 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WLWeiwei Li
Weiwei Li
QTQing-Yun Tian
Qing-Yun Tian
BLBen Liu
Ben Liu
JCJason Cuellar
Jason Cuellar
BRBrendon Richbourgh
Brendon Richbourgh
CLChuanju Liu
Chuanju Liu
Intervertebral disc (IVD) degeneration is a common degenerative disease, yet much is unknown about the mechanisms during its pathogenesis. Herein we investigated whether progranulin (PGRN), a chondroprotective growth factor, is associated with IVD degeneration. PGRN was detectable in both human and murine IVD. The levels of PGRN were upregulated in murine IVD tissue during aging process. Loss of PGRN resulted in an early onset of degenerative changes in the IVD tissue and altered expressions of the degeneration-associated molecules in the mouse IVD tissue. Moreover, PGRN knockout mice exhibited accelerated IVD matrix degeneration, abnormal bone formation and exaggerated bone resorption in vertebra with aging. The acceleration of IVD degeneration observed in PGRN null mice was probably due to the enhanced activation of NF-κB signaling and β-catenin signaling. Taken together, PGRN may play a critical role in homeostasis of IVD and may serve as a potential molecular target for prevention and treatment of disc degenerative diseases.

1 April 2017 in International Immunopharmacology
Verified
Journal Article
Closed access
WLWeiwei Li
Weiwei Li
WWWenhan Wang
Wenhan Wang
XWXihai Wu
Xihai Wu
XMXiaoqian Ma
Xiaoqian Ma
RQRuize Qu
Ruize Qu
WLWeiwei Li
Weiwei Li